Chromosome translocations: dangerous liaisons revisited
暂无分享,去创建一个
[1] J. Stephenson,et al. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22 , 1984, Cell.
[2] N. Heerema,et al. Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation. , 1998, Blood.
[3] T. Rabbitts,et al. Chromosomal abnormalities in lymphoid tumours: mechanism and role in tumour pathogenesis. , 1988, Trends in genetics : TIG.
[4] F. Oski,et al. Hematology of Infancy and Childhood , 1974 .
[5] J. Rowley,et al. Chromosome abnormalities in poorly differentiated lymphocytic lymphoma. , 1979, Cancer research.
[6] G. Klein,et al. Characteristic chromosomal abnormalities in biopsies and lymphoid‐cell lines from patients with burkitt and non‐burkitt lymphomas , 1976, International journal of cancer.
[7] D. Baltimore,et al. Abelson murine leukaemia virus protein is phosphorylated in vitro to form phosphotyrosine , 1980, Nature.
[8] R. Berger,et al. Philadelphia-positive acute leukemia. Cytogenetic and molecular aspects. , 1990, Cancer genetics and cytogenetics.
[9] Peter Beighton,et al. de la Chapelle, A. , 1997 .
[10] F. Mittelman. The Third International Workshop on Chromosomes in Leukemia. Lund, Sweden, July 21-25, 1980. Introduction. , 1981, Cancer genetics and cytogenetics.
[11] M. Ohki,et al. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[12] M. Stanulla,et al. DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis , 1997, Molecular and cellular biology.
[13] J. Teruya-Feldstein,et al. Recurring chromosomal abnormalities in non-Hodgkin's lymphoma: biologic and clinical significance. , 2000, Seminars in hematology.
[14] P. Leder,et al. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. Rowley,et al. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. , 1995, Blood.
[16] Zhen-yi Wang,et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. , 1988, Haematology and blood transfusion.
[17] M. Moore. The clinical use of colony stimulating factors. , 1991, Annual review of immunology.
[18] A. Levan. Some current problems of cancer cytogenetics. , 2009, Hereditas.
[19] D. Baltimore,et al. A normal cell protein cross-reactive to the major Abelson murine leukaemia virus gene product , 1979, Nature.
[20] J Erikson,et al. Differential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphoma. , 1983, Science.
[21] P. Nilsson,et al. Chromosome pattern, occupation, and clinical features in patients with acute nonlymphocytic leukemia. , 1981, Cancer genetics and cytogenetics.
[22] C. Bloomfield,et al. Clinical significance of chromosomal abnormalities in acute lymphoblastic leukemia. , 1984, Cancer genetics and cytogenetics.
[23] P. Jeffrey,et al. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. , 1994, Science.
[24] P. Nowell,et al. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. , 1984, Science.
[25] M. Freedman,et al. Fusion Between Transcription Factor CBFP/PEBP2I3 andaMyosin HeavyChain in AcuteMyeloid Leukemia , 1993 .
[26] R. Larson,et al. Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association. , 1983, The New England journal of medicine.
[27] Rowley Jd. Identificaton of a translocation with quinacrine fluorescence in a patient with acute leukemia. , 1973 .
[28] D. Hossfeld. E.S. Jaffe, N.L. Harris, H. Stein, J.W. Vardiman (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues , 2002 .
[29] N. Heisterkamp,et al. Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia , 1987, Cell.
[30] G. Daley,et al. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. , 1990, Science.
[31] A. Sandberg. Second International Workshop on Chromosomes in Leukemia. , 1980, Cancer research.
[32] F. Mitelman,et al. Catalog of Chromosome Aberrations in Cancer , 1996, British Journal of Cancer.
[33] J. Rowley,et al. Nonrandom chromosomal abnormalities in acute nonlymphocytic leukemia in patients treated for Hodgkin disease and non-Hodgkin lymphomas , 1977 .
[34] S. Korsmeyer,et al. Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia. , 1991, Science.
[35] R. Palmiter,et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice , 1985, Nature.
[36] C. Bloomfield,et al. Fourth International Workshop on Chromosomes in Leukemia 1982: Clinical significance of chromosomal abnormalities in acute nonlymphoblastic leukemia. , 1984, Cancer genetics and cytogenetics.
[37] Theodor Boveri. Zur Frage der Entstehung maligner Tumoren , 1914 .
[38] J. Stephenson,et al. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia , 1982, Nature.
[39] F. Collins,et al. Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. , 1993, Science.
[40] T. Glover. Catalog of chromosome aberrations in cancer, 4th ed , 1992 .
[41] C. Sawyers,et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. , 2001, The New England journal of medicine.
[42] K Wheatley,et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. , 1998, Blood.
[43] J. Birch. Genes and cancer , 1999, Archives of disease in childhood.
[44] F. Alt,et al. The CBFβ Subunit Is Essential for CBFα2 (AML1) Function In Vivo , 1996, Cell.
[45] David L. Vaux,et al. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.
[46] N. Zhao,et al. Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[47] J. Lilleyman. Hematology of Infancy and Childhood , 1993 .
[48] B. Roe,et al. DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis. , 2000, Human molecular genetics.
[49] C. Croce,et al. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[50] C. Croce,et al. A common mechanism of chromosomal translocation in T- and B-cell neoplasia. , 1986, Science.
[51] J. Stephenson,et al. Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia , 1983, Nature.
[52] Susan M. Watanabe,et al. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity , 1984, Cell.
[53] C. Croce,et al. Self-fusion of the ALL1 gene. A new genetic mechanism for acute leukemia. , 1995, JAMA.
[54] J. Rowley. A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining , 1973, Nature.
[55] P. Nowell,et al. A minute chromosome in human chronic granulocytic leukemia , 1960 .
[56] E. Canaani,et al. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia , 1985, Nature.